We Can Help with That
Treating relapsing forms of multiple sclerosis can be complicated—for patients, for their families and even for the health professionals who manage their care.
Mylan ADVOCATE® can help you overcome the barriers that may stand between you and your treatment—whether it’s making sure that your health plan’s “prior authorization” forms are filled out correctly or sending you a text reminder for your injection.
We’re there for you, with the support you need to stay on track.
Experienced Nurses Available
- Your condition
- Glatiramer Acetate Injection
- Proper injection technique
Our MS-experienced nurses can also work with you one-on-one to:
In-home injection training
You can call Mylan ADVOCATE® to schedule an in-home training session with one of our MS-experienced nurses, who can show you how to use the WhisperJECT® Autoinjector device or pre-filled glass syringe and guide you through each step of your injection. Please see the Instructions For Use provided with your WhisperJECT® Autoinjector device.
Your Benefits Advocate
You’ll have access to a trained Benefits Advocate—a go-to resource who can help you navigate through the requirements of your insurance plan, whether it’s private or government sponsored.
Your Benefits Advocate can help you by:
- Coordinating your insurance benefits
- Helping you fill out and file the right forms at the right time
- Assisting you in signing up for the Mylan ADVOCATE® Co-pay Program, if you’re eligible
- Helping to identify possible sources of financial assistance
MS Resources You Can Access Now
To find brochures, websites and more, on topics most relevant to you and your family and friends, visit our MS Resources page
Call Mylan ADVOCATE® today at 1.844.695.2667
Mylan ADVOCATE® Co-pay Program
As a leader in the manufacture of generic medications, Mylan is committed to making quality medicines more affordable.
With the Mylan ADVOCATE® Co-pay Program, your co-pay for Glatiramer Acetate Injection from Mylan could be as low as $0 a month.*
- No financial qualifications
- If your insurance has recently changed, contact Mylan ADVOCATE® to see if you are eligible for the Mylan ADVOCATE® Co-pay Program
For commercially insured patients:
You may be eligible to get your Glatiramer Acetate Injection prescription filled for a co-pay as low as $0.* Certain limits and restrictions apply. Call Mylan ADVOCATE® for more information on the Mylan ADVOCATE® Co-pay Program today 1.844.695.2667.
Terms and Conditions for $0 Co-pay
Eligibility Criteria Terms and Conditions
- This Mylan ADVOCATE® co-pay assistance program can be used to reduce the amount of an eligible patient’s out-of-pocket expenses for Mylan’s Glatiramer Acetate Injection 20mg/mL and/or 40mg/mL up to the full amount of the patient’s out-of-pocket expense per prescription, which may be up to a 90-day supply, subject to a maximum aggregate amount of $9,000 per 12-month period while this co-pay assistance program remains in effect (such aggregate amount includes dispenses of both Mylan’s Glatiramer Acetate Injection 20mg/mL and 40mg/mL). No other purchase is necessary. Valid prescription is required. Mylan reserves the right to amend or end this co-pay assistance program at any time without notice.
- Eligibility Requirements: This co-pay assistance can be redeemed only by patients or patient guardians who are 18 years of age or older and who are residents of the U.S. or Puerto Rico. Patients must have commercial prescription drug insurance. This co-pay assistance program is not valid for uninsured patients (but may be used by commercially insured patients without coverage for Mylan’s Glatiramer Acetate Injection 20mg/mL and/or 40mg/mL) and patients who are covered in whole or in part by any state or federally funded healthcare program, including, but not limited to, any state pharmaceutical assistance program, Medicare (Part D or otherwise), Medicaid, Medigap, VA or DOD, or TriCare (regardless of whether Mylan’s Glatiramer Acetate Injection 20mg/mL and/or 40mg/mL is covered by such government program); not valid if the patient is Medicare eligible and enrolled in an employer-sponsored health plan or prescription benefit program for retirees; and not valid if the patient’s insurance plan is paying the entire cost of this prescription. This co-pay assistance program is void outside the U.S. or Puerto Rico or in any state or jurisdiction where prohibited by law, taxed or restricted. Absent a change in Massachusetts law, this co-pay assistance program will no longer be valid for Massachusetts residents as of January 1, 2023. This co-pay assistance program is not valid for residents of California.
- This co-pay assistance program is not health insurance. The co-pay assistance program is not transferable, and the amount of the savings cannot exceed the patient’s out-of-pocket expenses. Cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. This co-pay assistance is not redeemable for cash.
- NOTICE: Data related to your use of this co-pay assistance program may be collected, analyzed and shared with Mylan for market research and other purposes related to assessing co-pay assistance programs. Data shared with Mylan will be aggregated and de-identified, meaning it will be combined with data related to other co-pay assistance program redemptions and will not identify you.
- Use of this co-pay assistance program must be consistent with the terms of any drug benefit provided by a commercial health insurer, health plan or private third-party payer. Patients must have not submitted and will not submit a claim for reimbursement under any federal, state or other governmental programs for this prescription. Patients are responsible for reporting the receipt of copay assistance to any commercial insurer, health plan, or third-party payer who pays for or reimburses any part of the prescription filled, as may be required. Patients should not use this co-pay assistance program if their health plan prohibits use of manufacturer co-pay assistance programs.
GLATIRAMER ACETATE INJECTION is a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
IMPORTANT SAFETY INFORMATION
Do not take GLATIRAMER ACETATE INJECTION if you are allergic to glatiramer acetate or mannitol.
Serious side effects may happen right after or within minutes after you inject glatiramer acetate injection at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain usually only lasts a few minutes or can begin around 1 month after you start using glatiramer acetate injection. Call your doctor right away if you experience chest pain.
A permanent indentation under the skin (lipoatrophy and, rarely, death of your skin tissue also referred to as necrosis) at the injection site may occur due to local destruction of fat tissue. In order to reduce your chance of developing these problems, be sure to follow your doctor's instruction on how to use glatiramer acetate injection and be sure to choose a different injection site each time you use glatiramer acetate injection.
Liver problems, including liver failure, can occur with GLATIRAMER ACETATE INJECTION. Call your healthcare provider right away if you have symptoms, such as nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, or sleepiness.
The most common side effects in studies of GLATIRAMER ACETATE INJECTION are redness, pain, swelling, itching, or a lump at the site of injection, rash, shortness of breath, and flushing. These are not all the possible side effects of GLATIRAMER ACETATE INJECTION. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects that you have while taking GLATIRAMER ACETATE INJECTION.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.